T cells in the control of organ-specific autoimmunity

被引:122
作者
Bluestone, Jeffrey A. [1 ]
Bour-Jordan, Helene [1 ]
Cheng, Mickie [1 ]
Anderson, Mark [1 ]
机构
[1] UCSF, Ctr Diabet, San Francisco, CA USA
关键词
EMBRYONIC STEM-CELLS; CUTTING EDGE; TOLERANCE INDUCTION; EPITHELIAL-CELLS; SELF-TOLERANCE; ANTI-CD3; MAB; NOD MICE; DISEASE PROGRESSION; MONOCLONAL-ANTIBODY; NEGATIVE SELECTION;
D O I
10.1172/JCI78089
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Immune tolerance is critical to the avoidance of unwarranted immune responses against self antigens. Multiple, non-redundant checkpoints are in place to prevent such potentially deleterious autoimmune responses while preserving immunity integral to the fight against foreign pathogens. Nevertheless, a large and growing segment of the population is developing autoimmune diseases. Deciphering cellular and molecular pathways of immune tolerance is an important goal, with the expectation that understanding these pathways will lead to new clinical advances in the treatment of these devastating diseases. The vast majority of autoimmune diseases develop as a consequence of-complex mechanisms that depend on genetic, epigenetic, molecular, cellular, and environmental elements and result in alterations in many different checkpoints of tolerance and ultimately in the breakdown of immune tolerance. The manifestations of this breakdown are harmful inflammatory responses in peripheral tissues driven by innate immunity and self antigen-specific pathogenic T and B cells. T cells play a central role in the regulation and initiation of these responses. In this Review we summarize our current understanding of the mechanisms involved in these fundamental checkpoints, the pathways that are defective in autoimmune diseases, and the therapeutic strategies being developed with the goal of restoring immune tolerance.
引用
收藏
页码:2250 / 2260
页数:11
相关论文
共 199 条
[71]   Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3γ1(Ala-Ala) [J].
Herold, KC ;
Burton, JB ;
Francois, F ;
Poumian-Ruiz, E ;
Glandt, M ;
Bluestone, JA .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (03) :409-418
[72]   Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus [J].
Herold, KC ;
Hagopian, W ;
Auger, JA ;
Poumian-Ruiz, E ;
Taylor, L ;
Donaldson, D ;
Gitelman, SE ;
Harlan, DM ;
Xu, DL ;
Zivin, RA ;
Bluestone, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (22) :1692-1698
[73]   Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial Metabolic and Immunologic Features at Baseline Identify a Subgroup of Responders [J].
Herold, Kevan C. ;
Gitelman, Stephen E. ;
Ehlers, Mario R. ;
Gottlieb, Peter A. ;
Greenbaum, Carla J. ;
Hagopian, William ;
Boyle, Karen D. ;
Keyes-Elstein, Lynette ;
Aggarwal, Sudeepta ;
Phippard, Deborah ;
Sayre, Peter H. ;
McNamara, James ;
Bluestone, Jeffrey A. .
DIABETES, 2013, 62 (11) :3766-3774
[74]   Type 1 diabetes: translating mechanistic observations into effective clinical outcomes [J].
Herold, Kevan C. ;
Vignali, Dario A. A. ;
Cooke, Anne ;
Bluestone, Jeffrey A. .
NATURE REVIEWS IMMUNOLOGY, 2013, 13 (04) :243-256
[75]   Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb teplizumab preserves insulin production for up to 5 years [J].
Herold, Kevan C. ;
Gitelman, Stephen ;
Greenbaum, Carla ;
Puck, Jennifer ;
Hagopian, William ;
Gottlieb, Peter ;
Sayre, Peter ;
Bianchine, Peter ;
Wong, Emelita ;
Seyfert-Margolis, Vicki ;
Bourcier, Kasia ;
Bluestone, Jeffrey A. .
CLINICAL IMMUNOLOGY, 2009, 132 (02) :166-173
[76]   GAD-alum treatment induces GAD65-specific CD4+CD25highFOXP3+ cells in type 1 diabetic patients [J].
Hjorth, Maria ;
Axelsson, Stina ;
Ryden, Anna ;
Faresjo, Maria ;
Ludvigsson, Johnny ;
Casas, Rosaura .
CLINICAL IMMUNOLOGY, 2011, 138 (01) :117-126
[77]   Redirecting human CD4+CD25+ regulatory T cells from the peripheral blood with pre-defined target specificity [J].
Hombach, A. A. ;
Kofler, D. ;
Rappl, G. ;
Abken, H. .
GENE THERAPY, 2009, 16 (09) :1088-1096
[78]   Control of regulatory T cell development by the transcription factor Foxp3 [J].
Hori, S ;
Nomura, T ;
Sakaguchi, S .
SCIENCE, 2003, 299 (5609) :1057-1061
[79]   An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires [J].
Hsieh, CS ;
Zheng, Y ;
Liang, YQ ;
Fontenot, JD ;
Rudensky, AY .
NATURE IMMUNOLOGY, 2006, 7 (04) :401-410
[80]   Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors [J].
Hsieh, CS ;
Liang, YQ ;
Tyznik, AJ ;
Self, SG ;
Liggitt, D ;
Rudensky, AY .
IMMUNITY, 2004, 21 (02) :267-277